Weight control and Obesity hypoventilation syndrome (ohs) - from FDA reports


Obesity hypoventilation syndrome (ohs) is reported only by a few people with Weight control. We study 4 people who have Obesity hypoventilation syndrome (ohs) and Weight control from FDA . Find out below who they are, other conditions they have and drugs they take.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 19, 2018

4 people who have Weight Control and Obesity Hypoventilation Syndrome (Ohs) are studied.


Number of reports submitted per year:

Would you have Obesity hypoventilation syndrome (ohs) when you have Weight control?

Gender of people who have Weight Control and experience Obesity Hypoventilation Syndrome (Ohs) *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Weight Control and experience Obesity Hypoventilation Syndrome (Ohs) *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Most common drugs for these people *:

  1. Zocor: 4 people, 100.00%
  2. Xenical: 4 people, 100.00%
  3. Temazepam: 4 people, 100.00%
  4. Atenolol: 4 people, 100.00%
  5. Insulin Insulatard Nph Nordisk: 1 person, 25.00%
Check whether a drug or a condition causes Obesity hypoventilation syndrome (ohs)

Top symptoms for these people *:

  1. Malaise (a feeling of general discomfort or uneasiness): 4 people, 100.00%
  2. Drug Effect Decreased: 4 people, 100.00%
  3. Oedema Lower Limb (fluid collection in tissue of lower leg): 1 person, 25.00%
  4. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Are you new to Weight control or have questions?

Volunteer or get paid to help people with your care experience




Related studies


Weight Control

Weight control can be treated by Phentermine, Phentermine hydrochloride, Adipex-p, Alli, Garcinia (latest reports from 30,792 Weight control patients)

Obesity Hypoventilation Syndrome (Ohs)

Obesity hypoventilation syndrome (ohs) (a condition in which severely overweight people fail to breathe rapidly enough) has been reported by people with high blood pressure, pain, osteoporosis, diabetes, oedema peripheral (latest reports from 212 Obesity hypoventilation syndrome (ohs) patients).


Drugs that are associated with Obesity hypoventilation syndrome (ohs)
Obesity hypoventilation syndrome (ohs) (274 drugs)
Other conditions that could cause Obesity hypoventilation syndrome (ohs)
Obesity hypoventilation syndrome (ohs) (113 conditions)
Browse all symptoms of Weight control
a b c d e f g h i j k l m n o p q r s t u v w x y z

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Weight control, Obesity hypoventilation syndrome (ohs)

Recent updates

General studies
Active Support Groups
Recent Care Guides

You could also:

  • Print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.